相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
A. H. V. Schapira et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Safinamide reduces dyskinesias and prolongs L-DOPA antiparkinsonian effect in parkinsonian monkeys
Laurent Gregoire et al.
PARKINSONISM & RELATED DISORDERS (2013)
A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
Fabrizio Stocchi et al.
MOVEMENT DISORDERS (2012)
The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
Lisa M. Shulman et al.
ARCHIVES OF NEUROLOGY (2010)
Parkinson's Disease and Motor Fluctuations
Vanessa K. Hinson
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2010)
Levodopa: Past, Present, and Future
Robert A. Hauser
EUROPEAN NEUROLOGY (2009)
Levodopa therapeutics for Parkinson's disease: new developments
Peter A. LeWitt
PARKINSONISM & RELATED DISORDERS (2009)
Levodopa-induced dyskinesias in Parkinson's disease: Etiology, impact on quality of life, and treatments
Elmyra V. Encarnacion et al.
EUROPEAN NEUROLOGY (2008)
Safinamide: Beyond MAO-B inhibition
C. Caccia et al.
PARKINSONISM & RELATED DISORDERS (2007)
Safinamide potentiates the effects of dopamine (DA)-agonists in early stage Parkinson's disease patients
R. Borgohain et al.
PARKINSONISM & RELATED DISORDERS (2007)
Long-term double-blind, placebo-controlled evaluation of the safety and efficacy of safinamide as an add-on to stable dopamine agonist therapy in patients with Parkinson's disease
R. Anand et al.
PARKINSONISM & RELATED DISORDERS (2007)
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease
M. Horstink et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Safinamide - From molecular targets to a new anti-Parkinson drug
C. Caccia et al.
NEUROLOGY (2006)
Symptom relief in Parkinson disease by safinamide - Biochemical and clinical evidence of efficacy beyond MAO-B inhibition
F. Stocchi et al.
NEUROLOGY (2006)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Impact of the motor complications of Parkinson's disease on the quality of life
S Chapuis et al.
MOVEMENT DISORDERS (2005)
Improvement of motor function in early Parkinson disease by safinamide
F Stocchi et al.
NEUROLOGY (2004)
Parkinson's disease home diary: Further validation and implications for clinical trials
RA Hauser et al.
MOVEMENT DISORDERS (2004)
Striatal glutamatergic mechanisms and extrapyramidal movement disorders
TN Chase et al.
NEUROTOXICITY RESEARCH (2003)
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia
RA Hauser et al.
CLINICAL NEUROPHARMACOLOGY (2000)
分享论文
